NEW MJ NEWS

Trulieve Announces May 2022 Event Participation

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced planned event participation in May.

Regenerative Cannabis Live, May 5, 2022: Founder and CEO Kim Rivers will participate in a keynote speech and panel discussion. Event details may be found here: https://regenerativecannabislive.com/

About Trulieve

Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

– ADVERTISEMENT –

Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve

Investor Contact
Christine Hersey, Executive Director of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Rob Kremer, Executive Director of Corporate Communications
+1 (404) 218-3077
Robert.Kremer@Trulieve.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-announces-may-2022-event-participation-301539180.html

SOURCE Trulieve Cannabis Corp.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

GrowGeneration (GRWG) Announces Inclusion in the Russell 2000 Index

GrowGeneration Announces Inclusion in the Russell 2000 Index GRWG -2.84% – GrowGeneration…

$MDBX Beefs Up Security… BIG TIME

Medbox Adds Former FBI Assistant Director of Security to Its Board LOS…

Tetra Bio-Pharma (TBPMF) Discusses FDA Orphan Drug Designation for Its Ophthalmic Program and Cannabinoid-Based Topical Cream

Tetra Bio-Pharma Discusses FDA Orphan Drug Designation for Its Ophthalmic Program and…